Why Shares of Coronavirus Stock Opko Health Plunged by 13% on Friday
Opko Health (NASDAQ: OPK) -- considered a coronavirus stock thanks to its BioReference Laboratories, which has diagnostics products that test for the globe's top health threat at the moment -- closed nearly 13% lower on Friday.
The apparent cause was the company's Q2 fiscal 2020 results, which clearly disappointed investors even though the healthcare company notched beats on both the top and bottom lines.
Image source: Getty Images.
Source Fool.com
